Saharek John's Insider Trades & SAST Disclosures
Saharek John's most recent trade in Harrow Health Inc was a trade of 277,200 Performance Stock Unit done . Disclosure was reported to the exchange on April 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Saharek John.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Harrow Health Inc | John Saharek P. | CEO & President, ImprimisRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2025 | 277,200 | 0 | - | - | Performance Stock Unit | |
| Harrow Health Inc | John Saharek P. | CEO & President, ImprimisRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2025 | 277,200 | 576,863 (2%) | 1% | 0 | Common Stock | |
| Harrow Health Inc | John Saharek P. | CEO & President, ImprimisRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.09 per share. | 03 Apr 2025 | 109,475 | 467,388 (1%) | 0% | 23.1 | 2,527,778 | Common Stock |
| Harrow Health Inc | John Saharek | CEO of ImprimisRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.37 per share. | 11 Sep 2024 | 90,000 | 344,803 (1%) | 0% | 7.4 | 663,300 | Common stock |
| Harrow Health Inc | John Saharek | CEO of ImprimisRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2024 | 90,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Harrow Health Inc | John Saharek | CEO of ImprimisRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.37 per share. | 11 Sep 2024 | 45,140 | 299,663 (1%) | 0% | 41.4 | 1,867,442 | Common stock |
| Harrow Health Inc | John Saharek | CEO of ImprimisRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 5,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Harrow Health Inc | John Saharek | CEO of ImprimisRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.75 per share. | 01 Mar 2024 | 5,000 | 254,803 (1%) | 0% | 8.8 | 43,750 | Common stock |
| Harrow Health Inc | Saharek John | CEO of ImprimisRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.67 per share. | 20 Feb 2024 | 30,000 | 262,419 (1%) | 0% | 10.7 | 320,100 | Common stock |
| Harrow Health Inc | Saharek John | CEO of ImprimisRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 30,000 | 0 | - | - | RSU | |
| Harrow Health Inc | John Saharek | CEO of ImprimisRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.67 per share. | 20 Feb 2024 | 12,616 | 249,803 (0%) | 0% | 10.7 | 134,613 | Common stock |
| Harrow Health Inc | John Saharek | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jul 2023 | 277,200 | 0 | - | - | Performance Stock Unit | |
| Harrow Health Inc | John Saharek | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jul 2023 | 277,200 | 331,277 (1%) | 1% | - | Common Stock | |
| Harrow Health Inc | John Saharek | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.23 per share. | 18 Jul 2023 | 109,080 | 222,197 (0%) | 0% | 18.2 | 1,988,528 | Common Stock |
| Harrow Health Inc | John Saharek | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 277,200 | 277,200 | - | - | Restricted Stock Unit | |
| Harrow Health Inc | John Saharek | President, ImprimisRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 50,000 | 0 | - | - | Restricted Stock Unit | |
| Harrow Health Inc | John Saharek | President, ImprimisRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 50,000 | 80,000 (0%) | 0% | - | Common Stock | |
| Harrow Health Inc | John Saharek | President, ImprimisRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.87 per share. | 19 Feb 2022 | 25,923 | 54,077 (0%) | 0% | 7.9 | 204,014 | Common Stock |
| Harrow Health Inc | John Saharek | President, ImprimisRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2021 | 277,200 | 277,200 | - | - | Restricted Stock Unit | |
| Harrow Health Inc | John Saharek | President, ImprimisRx | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 30,000 | 30,000 | - | - | Restricted Stock Unit |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges